“Build, License, Buy or Steal?”
For many businesses abundant R&D and patent filings provide a good foundation for innovation and sales freedom. But that may be changing.
Information technology companies are learning what Big Pharma realized some years ago: a strictly internal pipeline rarely is sufficient to fill all of most business’ IP needs. This is especially true in fast-growing consumer industries like mobility and social networking.
Says Bruce Berman in his bi-monthly column, The Intangible Investor: “When it comes to patents, it is sometimes more efficient to secure what is needed from others rather than roll the dice on what a business might be able to generate internally or get away with legally.”
It looks like a new role for C-level executives and activist investors may be emerging, now that IP value is on their radar.
Does this mean that highly significant patent portfolio or IP-based acquisitions will not get done without them? Should they?
A new level of IP/financial oversight will likely be good for most large businesses. Let’s hope we are right.
Image source: http://www.iam-magazine.com